During the first quarter of fiscal 2027, India's pharmaceutical exports soared to $8.10 billion, showcasing remarkable strength in drug formulations and biologicals, which together made up roughly three-quarters of the total. Both bulk drugs and vaccines saw substantial double-digit growth. North America and Europe served as vital markets for Indian medicines, indicating a promising future for the nation's pharmaceutical sector.

India's pharmaceutical exports reached $8.1 billion in Q1 FY27, driven by a 36% surge in vaccine shipments.

India’s pharmaceutical exports rose 6.8% to $8.1 billion in April-June FY27, with the US remaining the top market, Pharmexcil data showed. | India News